Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
Starlight Cardiovascular has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in May 2024.
Starlight Cardiovascular's investors include THE CATALYTIC IMPACT FOUNDATION (CIF), Consortium For Technology & Innovation in Pediatrics, National Heart, Lung and Blood Institute, Bird B..
Starlight Cardiovascular is headquartered in San Diego, United States.
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
Starlight Cardiovascular is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Starlight Cardiovascular — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/starlight-cardiovascular. Accessed August 15, 2026.
VCBacked. (2024). Starlight Cardiovascular — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/starlight-cardiovascular
{{cite web |title=Starlight Cardiovascular — Funding & Investors |url=https://www.vcbacked.co/company/starlight-cardiovascular |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated